FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158082138> ?p ?o ?g. }

• W2158082138 endingPage "117" @default.
• W2158082138 startingPage "111" @default.
• W2158082138 abstract "INTRODUCTION: We carried out a meta-analysis of data for 950 depressed patients from all double-blind, placebo-controlled comparative studies of moclobemide against imipramine. The aim of the analysis was to determine: 1 if the two antidepressants reduce anxiety symptoms as effectively as symptoms of depression; 2. if there are differences in the anti-anxiety effects; and 3. if the severity of anxiety symptoms influences the outcome of treatment. METHOD: The analysis was done in sub-groups of patients classified according to different definitions of anxiety and to the degree (mild, moderate, severe) of psychic and somatic anxiety present at baseline. The definitions and the criteria for the severity of anxiety were derived from the HAMD-17 anxiety item scores (items 10 and 11) and HAMD-17 anxiety sub-scales (ANXP and SOMA). The application of various definitions of anxiety (single-item and composite sub-scale scores) served to check the consistency, reproducibility and generalizability of the results. The criteria of efficacy and of the outcome of treatment, which were set in advance, were either: 50% reduction of the HAMD anxiety sub-scale; or percentage of global improvement (CGEA, very much and much) at the end of treatment (4 weeks). RESULTS: The results showed that moclobemide and imipramine are equally effective in reducing psychic and somatic anxiety in depressed patients, independent of the severity of anxiety or how it was defined. The criterion of 50% decrease of anxiety scores (at week 4) was consistently reached by 60-70% of patients in all drug sub-groups. The time course of effects on anxiety symptoms was similar with both drugs. It ran parallel to the regression of depression, with significant improvement of anxiety symptoms by week 2 on all measures. The frequency of benzodiazepine (BDZ) co-administration was not systematically correlated with the severity of anxiety. Moreover, co-prescription of BDZ did not change the outcome of drug treatment, with respect either to anxiety symptoms or global therapeutic efficacy. In placebo groups, significant negative interactions were found between severity of anxiety and the efficacy of treatment, which decreased with increased anxiety. The incidence of adverse events with moclobemide was barely higher than in the placebo group. Insomnia (4.9%) was the only adverse event significantly higher with moclobemide than with other treatments. Drop-out rates in drug groups were similar (27%) and unrelated to the severity of anxiety. In the placebo group, drop-outs were significantly higher than in drug groups (39%), and were positively correlated with the severity of anxiety. CONCLUSION: The results of this study indicate that anxiety symptoms in depressed patients respond similarly to moclobemide or imipramine and that the severity of these symptoms (or the co-prescription of benzodiazepine) has no influence on either the magnitude of anti-anxiety effects or on overall outcome. (Int J Psych Clin Pract 2000; 4:111-117)" @default.
• W2158082138 created "2016-06-24" @default.
• W2158082138 creator A5051895631 @default.
• W2158082138 date "2000-01-01" @default.
• W2158082138 modified "2023-09-26" @default.
• W2158082138 title "Comparative efficacy of antidepressants on anxiety features in depression: A meta-analysis of double-blind studies of imipramine and moclobemide against placebo" @default.
• W2158082138 cites W1976402477 @default.
• W2158082138 cites W2009966111 @default.
• W2158082138 cites W2013148689 @default.
• W2158082138 cites W2015283534 @default.
• W2158082138 cites W2033625070 @default.
• W2158082138 cites W2050715406 @default.
• W2158082138 cites W2053503259 @default.
• W2158082138 cites W2066899323 @default.
• W2158082138 cites W2145437658 @default.
• W2158082138 cites W2275487654 @default.
• W2158082138 cites W2401303826 @default.
• W2158082138 cites W2405023425 @default.
• W2158082138 cites W2415091003 @default.
• W2158082138 cites W2418299709 @default.
• W2158082138 doi "https://doi.org/10.1080/13651500050518262" @default.
• W2158082138 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24921445" @default.
• W2158082138 hasPublicationYear "2000" @default.
• W2158082138 type Work @default.
• W2158082138 sameAs 2158082138 @default.
• W2158082138 citedByCount "3" @default.
• W2158082138 crossrefType "journal-article" @default.
• W2158082138 hasAuthorship W2158082138A5051895631 @default.
• W2158082138 hasConcept C118552586 @default.
• W2158082138 hasConcept C142724271 @default.
• W2158082138 hasConcept C15744967 @default.
• W2158082138 hasConcept C204787440 @default.
• W2158082138 hasConcept C27081682 @default.
• W2158082138 hasConcept C2777127095 @default.
• W2158082138 hasConcept C2777198177 @default.
• W2158082138 hasConcept C2777696351 @default.
• W2158082138 hasConcept C2779145073 @default.
• W2158082138 hasConcept C2779177272 @default.
• W2158082138 hasConcept C2780237459 @default.
• W2158082138 hasConcept C558461103 @default.
• W2158082138 hasConcept C70410870 @default.
• W2158082138 hasConcept C71924100 @default.
• W2158082138 hasConceptScore W2158082138C118552586 @default.
• W2158082138 hasConceptScore W2158082138C142724271 @default.
• W2158082138 hasConceptScore W2158082138C15744967 @default.
• W2158082138 hasConceptScore W2158082138C204787440 @default.
• W2158082138 hasConceptScore W2158082138C27081682 @default.
• W2158082138 hasConceptScore W2158082138C2777127095 @default.
• W2158082138 hasConceptScore W2158082138C2777198177 @default.
• W2158082138 hasConceptScore W2158082138C2777696351 @default.
• W2158082138 hasConceptScore W2158082138C2779145073 @default.
• W2158082138 hasConceptScore W2158082138C2779177272 @default.
• W2158082138 hasConceptScore W2158082138C2780237459 @default.
• W2158082138 hasConceptScore W2158082138C558461103 @default.
• W2158082138 hasConceptScore W2158082138C70410870 @default.
• W2158082138 hasConceptScore W2158082138C71924100 @default.
• W2158082138 hasIssue "2" @default.
• W2158082138 hasLocation W21580821381 @default.
• W2158082138 hasLocation W21580821382 @default.
• W2158082138 hasOpenAccess W2158082138 @default.
• W2158082138 hasPrimaryLocation W21580821381 @default.
• W2158082138 hasRelatedWork W1977722472 @default.
• W2158082138 hasRelatedWork W2006059345 @default.
• W2158082138 hasRelatedWork W2074911125 @default.
• W2158082138 hasRelatedWork W2077887798 @default.
• W2158082138 hasRelatedWork W2114274610 @default.
• W2158082138 hasRelatedWork W2145437658 @default.
• W2158082138 hasRelatedWork W2156216169 @default.
• W2158082138 hasRelatedWork W2158082138 @default.
• W2158082138 hasRelatedWork W2386358940 @default.
• W2158082138 hasRelatedWork W2435172896 @default.
• W2158082138 hasVolume "4" @default.
• W2158082138 isParatext "false" @default.
• W2158082138 isRetracted "false" @default.
• W2158082138 magId "2158082138" @default.
• W2158082138 workType "article" @default.